talinolol

Small moleculeexperimental

Talinolol is a beta blocker. — Wikipedia

Clinical trial activity

4 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Jun 1, 2007 (NCT02514941)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1
Mol. weight
363.5 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane
  • cordanum
  • cordanum
  • (+-)-n-cyclohexyl-n'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea
  • racemic talinolol
  • talinolol
  • talinolol
  • talinolol
  • talinolol
  • talinolol
  • talinolol
  • talinolol
  • talinolol
  • (+/-)-talinolol
  • talinolol acetate
  • talinolol benzoate
  • talinolol hydrochloride
  • talinolol, (+-)-isomer
  • talinolol monoacetate
  • talinolol monohydrochloride
  • talinolol mononitrate
  • talinolol monosalicylate
  • talinolol nitrate
  • talinolol oxalate
  • talinolol oxalate (2:1)
  • talinolol salicylate
  • talinolol sulfate
  • talinolol sulfate (2:1)
  • talinolol tartrate (2:1), l-(+)-isomer
  • talinolol tartrate, l-(+)-isomer

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01788254Phase 1Jan 1, 2012University of Tuebingen
NCT01635608Phase 1Apr 1, 2011University of Greifswald
NCT01845194Phase 1Dec 1, 2009University of Goettingen
NCT02514941Phase 1Jun 1, 2007University of Greifswald
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of GreifswaldAcademic/Hospital2212007
University of GoettingenAcademic/Hospital1112009
University of TuebingenAcademic/Hospital1112012
3 organizations
Page 1 / 1